Cor Therapeutics Inc. announced Thursday that theunderwriters of its recent follow-on public stock offering of 3million newly issued shares have exercised their option topurchase an additional 450,000 shares. The final proceeds toCor (NASDAQ:CORR) from the offering totaled about $49.1million.
The underwriting group was managed by Robertson, Stephens& Co. L.P. and Montgomery Securities.
Cor of South San Francisco, Calif., now has 20.75 million fullydiluted shares outstanding. The stock closed unchangedThursday at $16.75 a share.
(c) 1997 American Health Consultants. All rights reserved.